NDC 55651-031 - Biomedic Artificial Tears
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55651-031
- Package NDCs from labels
- 55651-031-01
- Manufacturer
- KC Pharmaceuticals, Inc.
- Effective date
- 2025-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Biomedic Artificial Tears 15mL (MFR - EXPORT) | KC Pharmaceuticals, Inc. | 2025-12-31 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55651-031-01 | Biomedic Artificial Tears | 1 in 1 CARTON | LIQUID | 1 | 2 | |
| 55651-031-01 | Biomedic Artificial Tears | 15 mL in 1 BOTTLE, PLASTIC | LIQUID | 15 | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hand Wash | BENZALKONIUM CHLORIDE | Permatex | cfd3279e-9584-49d7-bf4b-6ef00d501d9b | 2026-02-04 | Warnings, Adverse reactions | F5UM2KM3W7 |
| RoyceDerm Antibacterial Body Wash | BENZALKONIUM CHLORIDE 0.13% | RoyceDerm LLC | 4a0c66b1-5a6f-b9b9-e063-6294a90a3d77 | 2026-02-04 | Warnings | F5UM2KM3W7 |
| Potassium Chloride | POTASSIUM CHLORIDE | Major Pharmaceuticals | 5c2e888c-2f1e-4d5a-a456-20774ca83302 | 2026-02-04 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride Extended-Release | POTASSIUM CHLORIDE | Major Pharmaceuticals | 7d74652b-3513-4ebb-8b47-10b3603d04a7 | 2026-02-04 | Warnings, Adverse reactions | 660YQ98I10 |
| 0.9 percentsaline | SODIUM CHLORIDE | Huizhou Jinsheng Medical Technology Co., Ltd | 487cb4fc-2e0b-020f-e063-6294a90a4526 | 2026-02-03 | Warnings | 451W47IQ8X |
| 0.9saline | SODIUM CHLORIDE | Huizhou Jinsheng Medical Technology Co., Ltd | 49e76aca-ca2b-3b95-e063-6394a90a875e | 2026-02-03 | Warnings | 451W47IQ8X |
| 0.9%saline | SODIUM CHLORIDE | Huizhou Jinsheng Medical Technology Co., Ltd | 49e7b329-e4e5-6991-e063-6294a90ac817 | 2026-02-03 | Warnings | 451W47IQ8X |
| Hand Wash | BENZALKONIUM CHLORIDE | Demoulas Super Markets, Inc | 3fe61130-9ec2-4e71-b147-320a81c4344c | 2026-02-03 | Warnings, Adverse reactions | F5UM2KM3W7 |
| Escudo Ultra-Protect Original | BENZALKONIUM CHLORIDE | Indelpa, Inc | 1cd4c38f-8156-bd74-e063-6394a90a9f56 | 2026-02-03 | Warnings | F5UM2KM3W7 |
| Escudo Ultra-Protect Soft Care | BENZALKONIUM CHLORIDE | Indelpa, Inc. | 1cc4b68b-dceb-3fab-e063-6294a90ab112 | 2026-02-03 | Warnings | F5UM2KM3W7 |
| WIPES4HEALTH | BENZALKONIUM CHLORIDE | Bubble Marketing LLC | 5d6dd15b-d087-4f25-bd2b-035ecacd5f97 | 2026-02-03 | Warnings | F5UM2KM3W7 |
| Foaming Hand | BENZALKONIUM CHLORIDE | Cintas Corporation | 17fb34e7-c9e6-41aa-991f-bb54c84ed79c | 2026-02-02 | Warnings, Adverse reactions | F5UM2KM3W7 |
| RELEEV Cold Sore Treatment | BENZALKONIUM CHLORIDE | Merix Pharmaceutical Corp. | fcef2fd3-2f32-4fb0-b396-ba4481ca4ccf | 2026-02-02 | Warnings | F5UM2KM3W7 |
| CLUB WIPES USA SANITIZING WIPES | BENZALKONIUM CHLORIDE | Bubble Marketing LLC | a0e4b04c-2227-49d2-8ccc-c7647b07cb02 | 2026-02-02 | Warnings | F5UM2KM3W7 |
| POTASSIUM CHLORIDE EXTENDED RELEASE | POTASSIUM CHLORIDE | Rising Pharma Holdings, Inc. | 947c11ca-ca0c-42df-8cc5-3db06458ca5b | 2026-02-01 | Warnings, Adverse reactions | 660YQ98I10 |
| SUTAB | SODIUM SULFATE, MAGNESIUM SULFATE, AND POTASSIUM CHLORIDE | Azurity Pharmaceuticals, Inc. | c020e973-dccf-4862-999e-17db6209a48a | 2026-01-31 | Warnings, Adverse reactions | 660YQ98I10 |
| Adrenal Support | ADRENALINUM, BERBERIS VULGARIS, ARGENTUM NITRICUM, NATRUM MURIATICUM, VANADIUM METALLICUM, OLEUM MORRHUAE, PETROLEUM | NaturalCare | cee52757-a86e-4251-b65f-954ac85f4e7e | 2026-01-30 | Warnings | 451W47IQ8X |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-01-30 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.